Skip to main content
Clinical Trials/IRCT2017080435442N1
IRCT2017080435442N1
Completed
Phase 1

A Clinical trial to evaluate the effects of intrapulmonary injection of bone marrow derived mononuclear cells along with pulmonary hypertension drugs on pulmonary pressure in patients with Eisenmenger syndrome

Vice chancellor for research, Shiraz University of Medical Sciences0 sites5 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor for research, Shiraz University of Medical Sciences
Enrollment
5
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • operated VSD (ventricular septal defect) and pulmonary hypertension (Eisenmenger)? not improved pulmunary HTN 2years after surgery (despite recieving routine medical therapy)
  • Exclusion criteria: absence of consent? finding clot in heart? not tolerating catheterism

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials